Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Still Wondering?
View:
Post by Gorf79 on Jun 26, 2022 8:31am

Still Wondering?

How a 32 person company from the Wes Mall beat out Baxter, Fresenius and Tablo on the ARC deal. One of the industry's largest in years!

Shouldn't Seto and Kellum be documenting this win for shareholders so we can truly understand our competitive advantages over the competition?

The deal was more or less presented as an oh well event, without explaining the paradigm shifting advantages of SAMI that will allow it to own this market for years!
Comment by Gorf79 on Jun 26, 2022 3:48pm
It could have been a simple case of submitting the RFP bid and Dr Kellum making one phone call to the CMO and buying group of ARC. Although something tells me every CMO and senior buyer across the dialysis industry by now knows exactly where Kellum is, and what his Dialco suite of products represents. if they don't win 60% Of future US dialysis unit contracts over the next decade I'd be ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities